|
26 Companies |
|
51 Products |
|
51 Products |
|
56 Mechanisms of Action |
|
3 Trials |
|
839 News |
|
| «12...567891011121314151617» |
- Clinical: Microencapsulated Fish Oil or Conjugated Linoleic Acid in Metabolic Syndrome (clinicaltrials.gov) - Jul 8, 2014
P=N/A, N=37, Completed, Sponsor: Universidade Federal do Rio de Janeiro
- Enrollment open: HDL: Study of the Impact of Dairy Fat on Cardiovascular Health. (clinicaltrials.gov) - Jul 8, 2014
P=N/A, N=90, Recruiting, Sponsor: Laval University
Not yet recruiting --> Recruiting
- Trial completion, Enrollment change, Compliance: Effect of Physical Activity and Diet on the Treatment of Metabolic Syndrome (clinicaltrials.gov) - Jul 8, 2014
P=N/A, N=150, Completed, Sponsor: University Hospital, Clermont-Ferrand
Not yet recruiting --> Recruiting Recruiting --> Completed | N=120 --> 150
- Enrollment open: Magnesium and Metabolic Syndrome: A Dose-response Meta-analysis (clinicaltrials.gov) - Jul 2, 2014
P=N/A, N=12, Recruiting, Sponsor: The Catholic University of Korea
Recruiting --> Completed | N=120 --> 150 Not yet recruiting --> Recruiting
- Trial primary completion date: Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis (clinicaltrials.gov) - Jun 27, 2014
P3, N=60, Recruiting, Sponsor: Bambino Ges
Not yet recruiting --> Recruiting Trial primary completion date: Oct 2013 --> Jun 2014
- Enrollment change: Metabolically Normal and Metabolically Abnormal Obesity (clinicaltrials.gov) - Jun 27, 2014
P=N/A, N=40, Recruiting, Sponsor: Washington University School of Medicine
Trial primary completion date: Oct 2013 --> Jun 2014 N=28 --> 40
- Phase classification: Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis (clinicaltrials.gov) - Jun 27, 2014
P3, N=60, Recruiting, Sponsor: Bambino Ges
N=28 --> 40 Phase classification: P1/2 --> P3
- Clinical: Mediterranean Diet and Protein-Sparing Modified Diet for Metabolic Syndrome in Liver Transplant Recipients (clinicaltrials.gov) - Jun 27, 2014
P=N/A, N=45, Not yet recruiting, Sponsor: The Cleveland Clinic
- | Enrollment open, Phase classification, Trial primary completion date: Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis (clinicaltrials.gov) - Jun 27, 2014
P3, N=60, Recruiting, Sponsor: Bambino Ges
Phase classification: P1/2 --> P3 Not yet recruiting --> Recruiting | Phase classification: P1/2 --> P3 | Trial primary completion date: Oct 2013 --> Jun 2014
- Enrollment closed: Comorbidities and Virologic Outcome Among Patients on Anti-retroviral Therapy in Rural Lesotho (clinicaltrials.gov) - Jun 27, 2014
P=N/A, N=1000, Active, not recruiting, Sponsor: Swiss Tropical & Public Health Institute
Not yet recruiting --> Recruiting | Phase classification: P1/2 --> P3 | Trial primary completion date: Oct 2013 --> Jun 2014 Recruiting --> Active, not recruiting
- Trial completion: Effects of Dietary Fibre on Glucose Metabolism and Satiety (clinicaltrials.gov) - Jun 27, 2014
P0, N=19, Completed, Sponsor: Lund University
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Trial termination: The Effects of the Telomerase Activator TA-65 on Insulin Resistance, Inflammation, and Metabolic Syndrome (clinicaltrials.gov) - Jun 24, 2014
P1, N=13, Terminated, Sponsor: University of Connecticut
Active, not recruiting --> Completed Recruiting --> Terminated; non-compliance issues
- Enrollment change, Trial termination: The Effects of the Telomerase Activator TA-65 on Insulin Resistance, Inflammation, and Metabolic Syndrome (clinicaltrials.gov) - Jun 24, 2014
P1, N=13, Terminated, Sponsor: University of Connecticut
Recruiting --> Terminated; non-compliance issues N=45 --> 13 | Recruiting --> Terminated; non-compliance issues
- Trial completion: Angiotensin Converting Enzyme Inhibitors and Periprocedural Myocardial Infarction (clinicaltrials.gov) - Jun 22, 2014
P=N/A, N=459, Completed, Sponsor: Ankara University
N=45 --> 13 | Recruiting --> Terminated; non-compliance issues Recruiting --> Completed
- Trial primary completion date: OBEFITT: Evaluation of the Impact of Physical Reconditioning Associated With Specific Nutritional Supplementation in Obese Patients Suffering From Metabolic Syndrome (clinicaltrials.gov) - Jun 19, 2014
P=N/A, N=100, Recruiting, Sponsor: University Hospital, Rouen
Recruiting --> Completed Trial primary completion date: Mar 2014 --> Dec 2014
- ||| candesartan cilexetil / Generic mfg.
Clinical: Blopress Tablets Specified Drug-use Survey "Hypertension: Survey on Patients With Metabolic Syndrome" (clinicaltrials.gov) - Jun 19, 2014
P=N/A, N=14151, Completed, Sponsor: Takeda
- Enrollment change: Bed Rest, Alternate Daily Fasting and Incretin Effect (clinicaltrials.gov) - Jun 4, 2014
P=N/A, N=30, Recruiting, Sponsor: Rigshospitalet, Denmark
Trial primary completion date: Mar 2014 --> Dec 2014 N=20 --> 30
- Enrollment open: Bed Rest, Alternate Daily Fasting and Incretin Effect (clinicaltrials.gov) - Jun 4, 2014
P=N/A, N=30, Recruiting, Sponsor: Rigshospitalet, Denmark
N=20 --> 30 Not yet recruiting --> Recruiting
- Trial primary completion date: REDUCS: Reduction of Sweetened Beverages and Intrahepatic Fat (clinicaltrials.gov) - Jun 2, 2014
P=N/A, N=29, Completed, Sponsor: University of Lausanne
Not yet recruiting --> Recruiting Trial primary completion date: Aug 2013 --> Apr 2014
- Enrollment change: REDUCS: Reduction of Sweetened Beverages and Intrahepatic Fat (clinicaltrials.gov) - Jun 2, 2014
P=N/A, N=29, Completed, Sponsor: University of Lausanne
Trial primary completion date: Aug 2013 --> Apr 2014 N=68 --> 29
- Trial completion: REDUCS: Reduction of Sweetened Beverages and Intrahepatic Fat (clinicaltrials.gov) - Jun 2, 2014
P=N/A, N=29, Completed, Sponsor: University of Lausanne
N=68 --> 29 Recruiting --> Completed
- New P2 trial: Tart Cherry, Metabolic Syndrome, and Cardiovascular Risk (clinicaltrials.gov) - Jun 1, 2014
P2, N=28, Recruiting, Sponsor: Florida State University
- Enrollment open: Comorbidities and Virologic Outcome Among Patients on Anti-retroviral Therapy in Rural Lesotho (clinicaltrials.gov) - May 30, 2014
P=N/A, N=1000, Recruiting, Sponsor: Swiss Tropical & Public Health Institute
Recruiting --> Completed Not yet recruiting --> Recruiting
- Trial completion: Telemedical Coaching for Weight Loss (clinicaltrials.gov) - May 27, 2014
P=N/A, N=100, Completed, Sponsor: West German Center of Diabetes and Health
Not yet recruiting --> Recruiting Enrolling by invitation --> Completed
- Clinical: An Antiinflammatory Diet as Modulator of Cardiometabolic Risk and Body Weight in Healthy Subjects (clinicaltrials.gov) - May 26, 2014
P=N/A, N=50, Recruiting, Sponsor: Lund University
- Trial primary completion date, IO biomarker: Impact of Flaxseed on the Syndrome Metabolic Inflammation (clinicaltrials.gov) - May 20, 2014
P=N/A, N=52, Completed, Sponsor: University of Sao Paulo
Enrolling by invitation --> Completed Trial primary completion date: Jan 2009 --> Jun 2007
- Trial primary completion date: Glycemic Index - Variability Among Individuals (clinicaltrials.gov) - May 20, 2014
P=N/A, N=124, Recruiting, Sponsor: Tufts University
Trial primary completion date: Jan 2009 --> Jun 2007 Trial primary completion date: Jun 2014 --> Dec 2014
- Trial initiation date, IO biomarker: Impact of Flaxseed on the Syndrome Metabolic Inflammation (clinicaltrials.gov) - May 20, 2014
P=N/A, N=52, Completed, Sponsor: University of Sao Paulo
Trial primary completion date: Jun 2014 --> Dec 2014 Initiation date: Jan 2008 --> Mar 2007
- Trial completion date, IO biomarker: Impact of Flaxseed on the Syndrome Metabolic Inflammation (clinicaltrials.gov) - May 20, 2014
P=N/A, N=52, Completed, Sponsor: University of Sao Paulo
Initiation date: Jan 2008 --> Mar 2007 Trial completion date: Jan 2009 --> Jun 2007
- Trial completion date: Glycemic Index - Variability Among Individuals (clinicaltrials.gov) - May 20, 2014
P=N/A, N=124, Recruiting, Sponsor: Tufts University
Trial completion date: Jan 2009 --> Jun 2007 Trial completion date: Dec 2014 --> Jun 2015
- Clinical: Effects of Yoga on Metabolic Syndrome (clinicaltrials.gov) - May 14, 2014
P=N/A, N=182, Completed, Sponsor: Angus Yu
- metformin / Generic mfg.
Trial completion: MVENT: Metformin in Preventing Androgen Deprivation Therapy Induced Insulin Resistance and Metabolic Syndrome (clinicaltrials.gov) - May 12, 2014
P2, N=28, Completed, Sponsor: Western Sydney Local Health District
Trial completion date: Dec 2014 --> Jun 2015 Active, not recruiting --> Completed
- Clinical: A Case Control Study of Resveratrol Effects in Coronary Artery Disease Patients With Metabolic Syndrome (clinicaltrials.gov) - May 11, 2014
P=N/A, N=20, Recruiting, Sponsor: Tehran University of Medical Sciences
- Trial completion date: Protein, Fiber, and Metabolic Syndrome - The PROFIMET Study (clinicaltrials.gov) - May 10, 2014
P=N/A, N=111, Completed, Sponsor: German Institute of Human Nutrition
Active, not recruiting --> Completed Trial completion date: Mar 2013 --> Jul 2013
- Clinical: Bed Rest, Alternate Daily Fasting and Incretin Effect (clinicaltrials.gov) - May 7, 2014
P=N/A, N=20, Not yet recruiting, Sponsor: Rigshospitalet, Denmark
- Trial primary completion date: GH and Cardiovascular Risk Factors (clinicaltrials.gov) - May 5, 2014
P4, N=32, Completed, Sponsor: VU University Medical Center
Trial completion date: Mar 2013 --> Jul 2013 Trial primary completion date: May 2014 --> Apr 2014
- Trial completion date: GH and Cardiovascular Risk Factors (clinicaltrials.gov) - May 5, 2014
P4, N=32, Completed, Sponsor: VU University Medical Center
Trial primary completion date: May 2014 --> Apr 2014 Trial completion date: May 2014 --> Apr 2014
- IO biomarker: Impact of Flaxseed on the Syndrome Metabolic Inflammation (clinicaltrials.gov) - May 5, 2014
P=N/A, N=52, Completed, Sponsor: University of Sao Paulo
- Trial completion: GH and Cardiovascular Risk Factors (clinicaltrials.gov) - May 5, 2014
P4, N=32, Completed, Sponsor: VU University Medical Center
Trial completion date: May 2014 --> Apr 2014 Recruiting --> Completed
- New P4 trial: Effect of Prolonged PDE-5 Inhibition on Insulin Signaling in Skeletal Muscle. (clinicaltrials.gov) - Apr 30, 2014
P4, N=16, Recruiting, Sponsor: Vanderbilt University
- Clinical: Comorbidities and Virologic Outcome Among Patients on Anti-retroviral Therapy in Rural Lesotho (clinicaltrials.gov) - Apr 28, 2014
P=N/A, N=1000, Not yet recruiting, Sponsor: Swiss Tropical & Public Health Institute
- Enrollment change: Angiotensin Converting Enzyme Inhibitors and Periprocedural Myocardial Infarction (clinicaltrials.gov) - Apr 25, 2014
P=N/A, N=410, Recruiting, Sponsor: Ankara University
Recruiting --> Completed N=300 --> 410
- Trial completion: Do Antidepressants Induce Metabolic Syndromes METADAP Study (clinicaltrials.gov) - Apr 15, 2014
P=N/A, N=624, Completed, Sponsor: Assistance Publique - H
N=300 --> 410 Recruiting --> Completed
- | New P2 trial: Effect of Implantable Contraception on Type-2 DM and Metabolic Syndrome in Women With History of Gestational DM (clinicaltrials.gov) - Apr 13, 2014
P2, N=260, Active, not recruiting, Sponsor: Mahidol University
- Trial completion: KWG: Acute Dose Response of Korean White Ginseng in Metabolic Syndrome or Type 2 Diabetes (clinicaltrials.gov) - Apr 13, 2014
P1, N=30, Completed, Sponsor: St. Michael's Hospital, Toronto
Recruiting --> Completed Recruiting --> Completed
- Trial completion: FLAB: Is Fructose Linked to Adiposity in Babies? (clinicaltrials.gov) - Apr 8, 2014
P=N/A, N=40, Completed, Sponsor: University of California, San Francisco
Recruiting --> Completed Active, not recruiting --> Completed
- triptorelin / Generic mfg.
Enrollment open: MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism (clinicaltrials.gov) - Apr 3, 2014
P4, N=20, Recruiting, Sponsor: Herlev Hospital
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Enbrel (etanercept) / Pfizer, Amgen
Trial termination: Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis (clinicaltrials.gov) - Apr 1, 2014
P=N/A, N=40, Terminated, Sponsor: Massachusetts General Hospital
Not yet recruiting --> Recruiting Recruiting --> Terminated; Difficulty in recruitment.
- triptorelin / Generic mfg.
New P4 trial: MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism (clinicaltrials.gov) - Apr 1, 2014
P4, N=20, Recruiting, Sponsor: Herlev Hospital
- Trial completion: Glucomannan Effects on Children With Non-alcoholic Fatty Liver Disease (clinicaltrials.gov) - Mar 31, 2014
P2, N=66, Completed, Sponsor: Bambino Ges
Recruiting --> Terminated; Difficulty in recruitment. Recruiting --> Completed